George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSophos Group Regulatory News (SOPH)

  • There is currently no data for SOPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Sophos Group plc

3 Dec 2019 15:24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sophos Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2 December 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 3p ordinary (GB00BYZFZ918)

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: 12,046,631 2.453% - -
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

12,046,631 2.453% - -

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit (GBP)
GB00BYZFZ918 CFD Reducing a long position 3,353 5.66
GB00BYZFZ918 CFD Closing a long position 27,482 5.66
GB00BYZFZ918 CFD Increasing a long position 531 5.66
GB00BYZFZ918 CFD Increasing a long position 3,353 5.66
GB00BYZFZ918 CFD Opening a short position 531 5.66
GB00BYZFZ918 CFD Closing a short position 531 5.66

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry d ate Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 3 December 2019
Contact name: Milos Naumovic
Telephone number: +44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005736/en/

Copyright Business Wire 2019

Date   Source Headline
14th Feb 20209:24 amRNSHolding(s) in Company
14th Feb 20209:22 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
14th Feb 20209:18 amRNSRule 2.9 Announcement
13th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
13th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
13th Feb 20202:38 pmRNSHolding(s) in Company
13th Feb 20202:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
13th Feb 20202:14 pmRNSForm 8.3 - Sophos Group PLC
13th Feb 20201:00 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:59 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:58 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:57 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:57 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:57 pmRNSForm 8.5 (EPT/RI)- Sophos Group plc AMENDMENT
13th Feb 202012:35 pmRNSDirector/PDMR Shareholding
13th Feb 202012:26 pmRNSHolding(s) in Company
13th Feb 202012:17 pmBUSForm 8.3 - SOPHOS GROUP PLC
13th Feb 202011:48 amRNSForm8.6(Public)JPM Fund ICVC-JPM UKEquityIndexFund
13th Feb 202011:36 amRNSForm 8.5 (EPT/RI)
13th Feb 202010:52 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
13th Feb 20209:44 amRNSForm 8.5 (EPT/RI)Sophos Group plc
13th Feb 20207:00 amRNSSatisfaction of Conditions & Scheme Timetable
12th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
12th Feb 20203:18 pmRNSHolding(s) in Company
12th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
12th Feb 20202:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
12th Feb 202012:25 pmBUSForm 8.3 - Sophos Group plc
12th Feb 202012:17 pmBUSForm 8.3 - SOPH LN Equity 11-February-20 Increase Traded Position
12th Feb 202011:19 amRNSForm 8.5 (EPT/RI)
12th Feb 202011:04 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
12th Feb 202010:37 amRNSRule 2.9 Announcement
12th Feb 202010:34 amRNSForm 8.3 - Sophos Group plc
12th Feb 202010:32 amRNSForm 8.5 (EPT/RI) - Sophos Group plc Replacement
12th Feb 202010:26 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
11th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
11th Feb 20203:17 pmBUSForm 8.3 - Sophos Group plc
11th Feb 202012:28 pmBUSFORM 8.3 - SOPHOS GROUP PLC
11th Feb 202011:37 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
11th Feb 202011:24 amRNSForm 8.5 (EPT/RI)
11th Feb 20209:37 amRNSForm 8.5 (EPT/RI)Sophos Group plc
11th Feb 20208:43 amRNSHolding(s) in Company
11th Feb 20207:43 amRNSRule 2.9 Announcement
10th Feb 20203:27 pmBUSForm 8.3 - Sophos Group plc
10th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
10th Feb 20202:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
10th Feb 202012:54 pmRNSForm 8.3 - Sophos Group Plc
10th Feb 202010:49 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
10th Feb 202010:45 amRNSForm 8.3 - Sophos Group Plc
10th Feb 202010:42 amBUSFORM 8.3 - SOPHOS GROUP PLC
10th Feb 202010:10 amRNSForm 8.5 (EPT/RI) - Sophos Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.